• Proceedings of the Korean Nuclear Society Conference
• /
• 1998.10a
• /
• pp.352-352
• /
• 1998

• Nuclear Engineering and Technology
• /
• v.55 no.2
• /
• pp.669-673
• /
• 2023

Introduction: The crucial step in preclinical process of radiopharmaceutical production is internal dosimetry evaluation by different ways to realize radiobiological dose-response relationships and to extract the results for clinical use. Till now several bone-seeking radiopharmaceuticals have been developed for bone metastasis. Interesting features of bisphosphonates attracted attentions to them in the field of radiopharmaceutical therapy and studies on new generation of them have been doing too. Materials and methods: In this study, we used ZNA as representative of the third generation. The radiopharmaceutical ¹⁸⁸Re-ZNA was produced and its radiochemical purity was investigated. Then, the biological distribution of the produced radiopharmaceutical at 1, 2, 4 and 24 h after injection on different organs of mice were investigated. Finally, the absorbed dose of organs in the human body was assessed using the RADAR method. Results: The results show 96% radiochemical purity of the ¹⁸⁸Re-ZNA radiopharmaceutical. The amount of %ID/g in bone is 1.131% after 1 h and in 24 h it has a significant amount compared to other organs, that is 0.516%. Also dosimetric results show that the highest absorption dose is related to bone and the amount of this dose is 0.050 mGy/MBq. Conclusion: Considering the possibility of producing the ¹⁸⁸Re-ZNA radiopharmaceutical, as well as the proper distribution of this radiopharmaceutical in target and non-target organs and increasing the absorbed dose in bone, it can be concluded that this radiopharmaceutical can be useful in the "radiopharmaceutical therapy" in metastases.

• Proceedings of the Korean Nuclear Society Conference
• /
• 1999.05a
• /
• pp.385-386
• /
• 1999

• 대한핵의학회:학술대회논문집
• /
• 1999.05a
• /
• pp.228-241
• /
• 1999

Percutaneous coronary angioplasty is well established therapeutic modality in the management of coronary artery disease. However, the high restenosis rate of 30 to 50% limits its usefulness. The principal mechanism of restenosis, intimal hyperplasia, is the proliferative response of vessel wall to injury, which consists largely of smooth muscle cells. A large body of animal investigations and a limited number of clinical studies have established the ability of ionizing radiation to reduce neointimal proliferation and restenosis rate significantly. Human studies have been reported that intravascular radiation after first restenosis inhibits a second restenosis. Encouraged by these reports, we are also conducting a double blind, placebo-controlled, randomized trial to evaluate this new therapeutic modality in patients with coronary artery stenosis. The objective of our trial is to determine the safety and efficacy of catheter-based solutional beta emitting radioisotope system in preventing restenosis after angioplasty. This review describes the vascular brachytherapy systems and isotopes that have been utilized in the initial clinical trials performed in this area of post PTCA coronary restenosis. The results of many worldwide ongoing clinical trials will determine whether this new technology will change the future practice of vascular intervention.

• Nuclear Medicine and Molecular Imaging
• /
• v.40 no.2
• /
• pp.127-131
• /
• 2006

Radiosynovectomy has been used as an effective treatment in patients with resistant synovitis after failure of long-term medication and intraarticular steroid injection. Although $^{90}Y$ silicate/citrate, $^{186}Re$ sulfide, and $^{169}Er$ citrate were approved in Europe for the appropriate radiopharmaceuticals for radiosynovectomy other radionuclides such as $^{32}P$-chromic phosphate, $^{165}Dy$-ferric hydroxide macroaggregate, $^{188}Rh$-microspheres, $^{153}Sm-particulate, and $^{166}Ho$-ferric hydroxide macroaggregate have been used in many countries. Reported success rates range from 40% to 90% for the different joints and underlying disease. In Korea, $^{188}Re$-tin-colloid and $^{166}Ho$-chitosan complex are now using as the major radionuclides in radiosynovectomy with good clinical results. A study on radiation synovectomy using $^{188}Re$-tin-colloid for patients with Korean rheumatoid arthritis shows the treatment resulted in the improvement of arthritis and well tolerated in our study, the radiosynovectomy with $^{166}Ho$-chitosan complex in 53 hemophilic patients markedly decreased intra-articular bleeding frequency and need for coagulation factor. This review inculdes general priciples in the application of radiosynovectomy and the clinical experience in Korea.

• Radioisotope journal
• /
• v.20 no.2
• /
• pp.4-5
• /
• 2005

• Journal of Ginseng Research
• /
• v.15 no.3
• /
• pp.188-191
• /
• 1991

The mild hydrolysis of ginsenosie Re with 50% acetic acid gave a prosapogenin mixture, 20(R)- and 20(S)-ginsenoside Rg2. The products were acetylated to give the peracetates, which were further converted into 20(R)- and 20(S)-ginsenoside Rh1 by the alcoholic alkaline treatment.

• Journal of The Korean Radiological Technologist Association
• /
• v.29 no.1
• /
• pp.219-219
• /
• 2003

• Wind and Structures
• /
• v.30 no.5
• /
• pp.475-483
• /
• 2020

This work investigates Reynolds number Re (= 50 - 200) effects on the flows around a single cylinder and the two tandem (center-to-center spacing L^⁎= L/D = 4) cylinders, each of a diameter D. Vorticity structures, Strouhal numbers, and time-mean and fluctuating forces are presented and discussed. For the single cylinder, with increasing Re in the range examined, the vorticity magnitude, Strouhal number and fluctuating lift all monotonically rise but time-mean drag, vortex formation length, and lateral distance between the two rows of vortices all shrink. For the two tandem cylinders, the increase in Re leads to the formation of three distinct flows, namely reattachment flow (50 ≤ Re ≤ 75), transition flow (75 < Re < 100), and coshedding flow (100 ≤ Re ≤ 200). The reattachment flow at Re = 50 is steady. When Re is increased from 75 to 200, the Strouhal number of the two cylinders, jumping from 0.113 to 0.15 in the transition flow regime, swells to 0.188. The two-cylinder flow is more sensitive to Re than the single cylinder flow. Fluctuating lift is greater for the downstream cylinder than the upstream cylinder while time-mean drag is higher for the upstream cylinder than for the other. The time-mean drags of the upstream cylinder and single cylinder behaves similar to each other, both declining with increasing Re.

• 대한핵의학회:학술대회논문집
• /
• 1999.05a
• /
• pp.196-199
• /
• 1999

Radiation synovetomy with various radiopharmaceuticals has been used to alleviate pain and swelling of rheumatoid arthritis and related joint diseases for more than 40 years. It is an attractive alternative to the surgical synovectomy for the management of the various joint diseases. Recently, the development of new radiopharmaceuticals labeled with $^{90}Y,\;^{32}P,\;^{186}Re,\;^{188}Re,\;^{153}Sm,\;^{165}Dy$ and $^{166}Ho$, for the effective management of synovial inflammation and related arthritic problems are gaining attention. In this article the general concepts and the clinical application of radiation synovectomy are reviewed.